Goldman Sachs’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $908M | Buy |
12,639,801
+4,416,955
| +54% | +$340M | 0.1% | 184 |
|
|
2025
Q4 | $653M | Buy |
8,222,846
+1,058,797
| +15% | +$83.5M | 0.08% | 224 |
|
|
2025
Q3 | $540M | Sell |
7,164,049
-329,780
| -4% | -$22.6M | 0.07% | 277 |
|
|
2025
Q2 | $517M | Sell |
7,493,829
-1,697,221
| -18% | -$111M | 0.07% | 270 |
|
|
2025
Q1 | $623M | Buy |
9,191,050
+3,855,730
| +72% | +$231M | 0.1% | 189 |
|
|
2024
Q4 | $240M | Sell |
5,335,320
-4,362,778
| -45% | -$245M | 0.04% | 444 |
|
|
2024
Q3 | $610M | Sell |
9,698,098
-289,716
| -3% | -$16.9M | 0.1% | 193 |
|
|
2024
Q2 | $590M | Sell |
9,987,814
-119,821
| -1% | -$7.5M | 0.1% | 194 |
|
|
2024
Q1 | $806M | Sell |
10,107,635
-2,758,651
| -21% | -$211M | 0.14% | 142 |
|
|
2023
Q4 | $1.02B | Buy |
12,866,286
+1,323,379
| +11% | +$94.2M | 0.19% | 90 |
|
|
2023
Q3 | $806M | Sell |
11,542,907
-686,159
| -6% | -$48.6M | 0.17% | 109 |
|
|
2023
Q2 | $845M | Sell |
12,229,066
-527,030
| -4% | -$37.5M | 0.18% | 95 |
|
|
2023
Q1 | $948M | Buy |
12,756,096
+2,930,426
| +30% | +$246M | 0.22% | 71 |
|
|
2022
Q4 | $916M | Buy |
9,825,670
+1,176,370
| +14% | +$114M | 0.22% | 73 |
|
|
2022
Q3 | $825M | Buy |
8,649,300
+508,343
| +6% | +$50.3M | 0.21% | 80 |
|
|
2022
Q2 | $754M | Buy |
8,140,957
+94,807
| +1% | +$9.25M | 0.19% | 90 |
|
|
2022
Q1 | $814M | Buy |
8,046,150
+510,424
| +7% | +$53.6M | 0.17% | 93 |
|
|
2021
Q4 | $777M | Sell |
7,535,726
-1,116,796
| -13% | -$103M | 0.15% | 105 |
|
|
2021
Q3 | $734M | Buy |
8,652,522
+2,189,537
| +34% | +$183M | 0.16% | 109 |
|
|
2021
Q2 | $539M | Buy |
6,462,985
+841,104
| +15% | +$68.9M | 0.12% | 150 |
|
|
2021
Q1 | $423M | Buy |
5,621,881
+162,670
| +3% | +$11.8M | 0.11% | 179 |
|
|
2020
Q4 | $373M | Sell |
5,459,211
-467,990
| -8% | -$30.4M | 0.1% | 191 |
|
|
2020
Q3 | $346M | Sell |
5,927,201
-1,799,567
| -23% | -$112M | 0.1% | 177 |
|
|
2020
Q2 | $502M | Sell |
7,726,768
-306,451
| -4% | -$19.3M | 0.15% | 118 |
|
|
2020
Q1 | $477M | Sell |
8,033,219
-1,134,191
| -12% | -$75.7M | 0.17% | 109 |
|
|
2019
Q4 | $681M | Buy |
9,167,410
+1,627,908
| +22% | +$114M | 0.17% | 105 |
|
|
2019
Q3 | $476M | Buy |
7,539,502
+578,586
| +8% | +$34.3M | 0.14% | 139 |
|
|
2019
Q2 | $379M | Buy |
6,960,916
+988,633
| +17% | +$53.2M | 0.11% | 173 |
|
|
2019
Q1 | $322M | Sell |
5,972,283
-1,617,794
| -21% | -$99.9M | 0.1% | 196 |
|
|
2018
Q4 | $497M | Buy |
7,590,077
+2,274,790
| +43% | +$170M | 0.16% | 100 |
|
|
2018
Q3 | $418M | Buy |
5,315,287
+68,153
| +1% | +$4.87M | 0.11% | 180 |
|
|
2018
Q2 | $338M | Sell |
5,247,134
-1,819,172
| -26% | -$120M | 0.09% | 208 |
|
|
2018
Q1 | $440M | Buy |
7,066,306
+1,203,683
| +21% | +$86.4M | 0.11% | 184 |
|
|
2017
Q4 | $425M | Sell |
5,862,623
-1,189,638
| -17% | -$86.5M | 0.1% | 195 |
|
|
2017
Q3 | $573M | Buy |
7,052,261
+381,207
| +6% | +$30.2M | 0.14% | 122 |
|
|
2017
Q2 | $537M | Buy |
6,671,054
+1,882,098
| +39% | +$149M | 0.14% | 123 |
|
|
2017
Q1 | $376M | Sell |
4,788,956
-179,407
| -4% | -$14.3M | 0.1% | 180 |
|
|
2016
Q4 | $392M | Buy |
4,968,363
+1,722,767
| +53% | +$139M | 0.11% | 164 |
|
|
2016
Q3 | $289M | Sell |
3,245,596
-640,192
| -16% | -$60.4M | 0.09% | 208 |
|
|
2016
Q2 | $372M | Buy |
3,885,788
+481,948
| +14% | +$48M | 0.12% | 141 |
|
|
2016
Q1 | $353M | Sell |
3,403,840
-788,470
| -19% | -$76.7M | 0.12% | 160 |
|
|
2015
Q4 | $410M | Buy |
4,192,310
+644,374
| +18% | +$63.1M | 0.13% | 150 |
|
|
2015
Q3 | $342M | Sell |
3,547,936
-788,801
| -18% | -$82.9M | 0.12% | 161 |
|
|
2015
Q2 | $455M | Sell |
4,336,737
-91,134
| -2% | -$9.31M | 0.14% | 131 |
|
|
2015
Q1 | $457M | Buy |
4,427,871
+449,002
| +11% | +$45.4M | 0.15% | 130 |
|
|
2014
Q4 | $383M | Buy |
3,978,869
+402,082
| +11% | +$35.4M | 0.12% | 161 |
|
|
2014
Q3 | $285M | Sell |
3,576,787
-1,000,729
| -22% | -$78.9M | 0.09% | 227 |
|
|
2014
Q2 | $345M | Buy |
4,577,516
+352,152
| +8% | +$26.6M | 0.11% | 180 |
|
|
2014
Q1 | $316M | Sell |
4,225,364
-213,734
| -5% | -$15.1M | 0.1% | 190 |
|
|
2013
Q4 | $318M | Buy |
4,439,098
+750,329
| +20% | +$48.2M | 0.1% | 201 |
|
|
2013
Q3 | $209M | Buy |
3,688,769
+438,151
| +13% | +$26.1M | 0.08% | 281 |
|
|
2013
Q2 | $186M | Buy |
+3,250,618
| New | +$188M | 0.07% | 305 |
|
Other funds holding CVS
VCM
VPM
Goldman Sachs's CVS Position: Q1 2026 in Review
Goldman Sachs increased its CVS Health (CVS) stake by 54% in Q1 2026, buying an estimated $340M and bringing the position to 12,639,801 shares worth $908M. The position accounts for 0.1% of the portfolio, ranked #184.
Goldman Sachs first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q4 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Goldman Sachs held 12,639,801 shares of CVS Health worth $908M as of Q1 2026.
- Goldman Sachs bought 4,416,955 CVS Health shares in Q1 2026, an estimated $340M.
- CVS Health made up 0.1% of Goldman Sachs's portfolio in Q1 2026, its #184 holding.
- Goldman Sachs first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's CVS Health position peaked at $1.02B in Q4 2023.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.